ACT

Athira Pharma Reports Full Year 2023 Financial Results and Pipeline and Business Updates

Retrieved on: 
Thursday, February 22, 2024

BOTHELL, Wash., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today reported financial results for the year ended December 31, 2023, and reviewed recent pipeline and business updates.

Key Points: 
  • In December 2023, the Company announced encouraging results from the exploratory Phase 2 SHAPE clinical trial to evaluate fosgonimeton in patients with Parkinson's disease dementia and dementia with Lewy bodies.
  • In May 2023, Athira selected the 40 mg dose for further development and potential regulatory approval.
  • In January 2024, Athira completed enrollment of the LIFT-AD study, randomizing approximately 315 patients in the primary analysis population.
  • In December 2023, Athira announced encouraging results from the exploratory SHAPE Phase 2 clinical trial of fosgonimeton for the potential treatment of Parkinson's disease dementia and dementia with Lewy bodies.

Clene Reports Significant Survival Benefit With CNM-Au8® Treatment in ALS EAP Compassionate Use Programs

Retrieved on: 
Thursday, February 22, 2024

CNM-Au8 30 mg treatment was well-tolerated, without a single serious adverse event attributed to CNM-Au8, and no significant safety findings reported.

Key Points: 
  • CNM-Au8 30 mg treatment was well-tolerated, without a single serious adverse event attributed to CNM-Au8, and no significant safety findings reported.
  • A pooled survival analysis of EAP participants treated with CNM-Au8 30 mg was compared to two independent datasets derived from PRO-ACT and the ALS/MND Natural History Consortium.
  • The EAP dataset was comprised of 256 participants with ALS of which 220 EAP participants had all baseline values available for matching.
  • The Sean M. Healey & AMG Center for ALS at Massachusetts General Hospital and Clene supported the first EAP (EAP01) launched in 2019.

Aduro Clean Technologies Announces Upcoming Conference Schedule and Engagement of Outside The Box Capital to Provide Marketing and Investor Relations Services

Retrieved on: 
Thursday, February 22, 2024

Additionally, the Company has entered into a new marketing and consulting agreement with Outside the Box Capital Inc .

Key Points: 
  • Additionally, the Company has entered into a new marketing and consulting agreement with Outside the Box Capital Inc .
  • to provide marketing and investor relations services.
  • The fourth edition of Chemical Recycling North America is a must-attend for professionals in the recycling and chemical industries.
  • The Company announces that it has entered into a marketing and consulting agreement (the “OTBC Agreement”) with an arm’s length marketing firm, Outside The Box Capital Inc. (“OTBC”) of Oakville Ontario, to provide marketing consulting and investor relations services, including marketing services through social media channels and online media distribution.

Enact Announces Quarterly Dividend

Retrieved on: 
Tuesday, February 20, 2024

RALEIGH, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that its Board of Directors declared a quarterly dividend of $0.16 per common share, payable on March 13, 2024, to shareholders of record on February 28, 2024.

Key Points: 
  • RALEIGH, N.C., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Enact Holdings, Inc. (Nasdaq: ACT) (Enact) a leading provider of private mortgage insurance through its insurance subsidiaries, today announced that its Board of Directors declared a quarterly dividend of $0.16 per common share, payable on March 13, 2024, to shareholders of record on February 28, 2024.
  • Future dividends will be subject to Board approval.

Capacity Trucks Celebrates 50th Anniversary Milestone

Retrieved on: 
Monday, March 4, 2024

Capacity Trucks, a subsidiary of REV Group, Inc. (NYSE: REVG) and trusted yard truck manufacturer, is celebrating its 50th anniversary this year.

Key Points: 
  • Capacity Trucks, a subsidiary of REV Group, Inc. (NYSE: REVG) and trusted yard truck manufacturer, is celebrating its 50th anniversary this year.
  • View the full release here: https://www.businesswire.com/news/home/20240304368107/en/
    Capacity Trucks, a subsidiary of REV Group, Inc. (NYSE: REVG) and trusted yard truck manufacturer, is celebrating its 50th anniversary this year.
  • “Over the last 50 years, Capacity has become an industry leader in terminal trucks, recognized for its robust manufacturing, high level of customization and durable products,” said Wes Downing, vice president and general manager of Capacity.
  • Key moments include:
    1974 – The smallest Capacity Truck was built for Kennedy Airport, 48” tall and 66” WB
    1988 – Capacity moved to its current location at 401 Capacity Drive, Longview, Texas
    1991 – The largest Capacity Truck was built for Tofeco Oil Field Co., over 43” feet long
    Stay up to date on Capacity’s 50th anniversary celebration all year on its social media platforms:

StandOut® Challenge Interview Overcomes the Basic Paradox of Traditional SAT/ACT Assessments

Retrieved on: 
Monday, March 4, 2024

These skills around work and study form the independent variables of academic and career success.

Key Points: 
  • These skills around work and study form the independent variables of academic and career success.
  • Using traditional achievement scores such as the ACT/SAT in college admissions presents another basic problem for schools seeking to enhance equality of opportunity: higher scores correlate most closely with higher family income.
  • Or 2) is the opposite true: that students who develop greater determination and skill at practice come from richer families?
  • The scoring phase of FocusRing requires students to listen to and learn from others as they perform their assigned evaluations.

Bart Valdez, CEO of Ingenovis Health, recognized by the Staffing Industry Association (SIA) on its Annual Staffing 100 North America List

Retrieved on: 
Thursday, February 29, 2024

Ingenovis Health announced today that CEO Bart Valdez was named to the 2024 Staffing Industry Analysts (SIA) Staffing 100 North America .

Key Points: 
  • Ingenovis Health announced today that CEO Bart Valdez was named to the 2024 Staffing Industry Analysts (SIA) Staffing 100 North America .
  • This is Valdez’s second consecutive year recognized on the list which honors the 100 most influential leaders whose work significantly impacts the workforce ecosystem.
  • His diverse leadership history includes driving innovation and excellence in clinical trials, human capital management and global talent acquisition.
  • Beyond his professional pursuits, Valdez, a first-generation college graduate, champions education by sponsoring first-generation students at Colorado State University.

Cannae Holdings, Inc. Commences Cash Tender Offer to Purchase Up to $200 Million in Value of Shares of its Common Stock

Retrieved on: 
Friday, March 1, 2024

The Company believes that the Offer is consistent with its long-term goal of driving shareholder value and closing this gap.

Key Points: 
  • The Company believes that the Offer is consistent with its long-term goal of driving shareholder value and closing this gap.
  • However, the Offer is subject to a number of other terms and conditions, which are described in detail in the Offer to Purchase.
  • The Offer Materials contain important information that holders are urged to read before any decision is made with respect to the Offer.
  • THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND IS NOT AN OFFER OR SOLICITATION TO PURCHASE SECURITIES.

Yale University Joins Dartmouth, MIT, and Georgetown in Requiring Applicants to Submit Standardized Test Scores; Kaplan Survey Suggests Other Schools Will Join Them

Retrieved on: 
Thursday, February 22, 2024

And results from Kaplan’s 2023 college admissions officers survey find that these schools may not be alone for long*.

Key Points: 
  • And results from Kaplan’s 2023 college admissions officers survey find that these schools may not be alone for long*.
  • Of the more than 200 test optional schools Kaplan surveyed late last year, 15 percent said they are considering reinstating or will definitely reinstate the requirement.
  • The survey also finds that among these same test optional schools, 67 percent say if a student submits a competitive SAT or ACT score , it helps their application.
  • Trends like this tend to have a snowball effect, so if more top schools bring back the requirement, expect more to follow.

Western Asset Term Funds Announce Stockholder Proposals

Retrieved on: 
Tuesday, February 20, 2024

Western Asset Investment Grade Defined Opportunity Trust Inc. (NYSE: IGI) and Western Asset Global Corporate Defined Opportunity Fund Inc. (NYSE: GDO) (individually, a “Fund” and collectively, the “Funds”) announced today approval by each Fund’s Board of Directors of a proposal that will allow stockholders of each Fund to remain invested, subject to stockholder approval.

Key Points: 
  • Western Asset Investment Grade Defined Opportunity Trust Inc. (NYSE: IGI) and Western Asset Global Corporate Defined Opportunity Fund Inc. (NYSE: GDO) (individually, a “Fund” and collectively, the “Funds”) announced today approval by each Fund’s Board of Directors of a proposal that will allow stockholders of each Fund to remain invested, subject to stockholder approval.
  • If a Fund’s net assets following the tender offer are expected to be $50 million or greater, the tender offer will be completed and such Fund’s term will be eliminated.
  • If a Fund’s term is eliminated, the Fund’s name will change to reflect the elimination to “Western Asset Investment Grade Opportunity Trust Inc.” and “Western Asset Global Corporate Opportunity Fund Inc.” for IGI and GDO, respectively.
  • The approval of each Fund’s Amendment Proposal is not contingent upon the approval of the other Fund’s Amendment Proposal.